WelcomeUser Guide
ToSPrivacyCanary
DonateBugsLicense

©2025 Poal.co

(post is archived)

[–] 0 pt

https://www.politifact.com/factchecks/2022/mar/31/facebook-posts/evidence-does-not-support-claim-pfizer-staged-osca/

Pfizer does not anticipate federal regulatory approval of ritlecitinib until at least 2023, according to the company’s December 2021 presentation to investors.